Scott R. Florell
( out of 32 reviews )

Scott R. Florell, MD

Languages spoken: English

Clinical Locations

University of Utah Hospital

Dermatology, Area E
Salt Lake City
801-581-2955

Veterans Administration Medical Center

Dermatology Clinic
Salt Lake City

  • Scott Florell, MD is one of four dermatopathologists in the department that analyzes skin biopsies. He uses his clinical and dermatopathology skills to assist our clinicians in diagnosing skin diseases. His main clinical focus I diagnosing and treating patients with skin cancer. Dr. Florell is board certified in anatomic and clinical pathology, dermatology and dermatopathology.

    Specialties

    Board Certification

    American Board of Dermatology (Dermatology)
    American Board of Dermatology (Sub: Dermatopathology)
    American Board of Pathology (Anatomic & Clinical)
    National Board of Medical Examiners

    Patient Rating

    4.9 /5
    ( out of 32 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our patient experience survey and displayed in their entirety.
    Patients are de-identified for confidentiality and patient privacy.

    October 05, 2024
    UH HOSPITALS AND CLINICS

    Discusses treatment options with me and respects my decisions

    September 07, 2024
    UH HOSPITALS AND CLINICS

    Dr Florell is always extremely attentive to both the medical needs and the humanity of the patient.

    September 07, 2024
    UH HOSPITALS AND CLINICS

    Dr. Florell is excellent.

    May 06, 2024
    UH HOSPITALS AND CLINICS

    Dr Florell is the person you want to see with dermatology problems.

    May 05, 2024
    UH HOSPITALS AND CLINICS

    Best doctor

    May 05, 2024
    UH HOSPITALS AND CLINICS

    You will get the very best care from Dr.Florell.He takes your condition and questions very seriously and works to give the best medicine always.

    May 05, 2024
    UH HOSPITALS AND CLINICS

    Dr Florell is consistently caring and remembers the uniqueness of each patient.

    April 09, 2024
    UH HOSPITALS AND CLINICS

    I would recommend Dr. Florell to anyone who is in need of care from a dermatologist.

    November 15, 2023
    UH HOSPITALS AND CLINICS

    Dr Florell consistently provides excellent care. He is very knowledgeable, skillful and personable. He provides thorough exams and clearly presents his findings and the treatment options. Also, he is a good listener and provides thoughtful and clear responses to questions.

    See More Patient Comments

  • Scott Florell, MD is one of four dermatopathologists in the department that analyzes skin biopsies. He uses his clinical and dermatopathology skills to assist our clinicians in diagnosing skin diseases. His main clinical focus I diagnosing and treating patients with skin cancer. Dr. Florell is board certified in anatomic and clinical pathology, dermatology and dermatopathology.

    Board Certification and Academic Information

    Academic Departments Dermatology -Primary
    Board Certification
    American Board of Dermatology (Dermatology)
    American Board of Dermatology (Sub: Dermatopathology)
    American Board of Pathology (Anatomic & Clinical)
    National Board of Medical Examiners

    Education history

    Residency Dermatology - University of Utah School of Medicine Resident
    Internal Medicine - University of Utah School of Medicine Intern
    Residency Pathology - University of Utah School of Medicine Resident
    Medicine - University of Nebraska - Omaha M.D.
    Undergraduate Biology - University of Nebraska - Lincoln B.S.

    Selected Publications

    Journal Article

    1. Gociman S, Wada DA, Bowen AR, Florell SR, Ng D, Madigan LM (2023). Young Woman With Annular and Purpuric Plaques in the Setting of High Fevers: Answer. Am J Dermatopathol, 45(5), 344-345. (Read full article)
    2. Gociman S, Wada DA, Bowen AR, Florell SR, Ng D, Madigan LM (2023). Young Woman With Annular and Purpuric Plaques in the Setting of High Fevers: Challenge. Am J Dermatopathol, 45(5), e32-e34. (Read full article)
    3. Wen-Ying Wong E, Pandeya S, Crandall H, Smart T, Dixon M, Boucher KM, Florell SR, Grossman D, Sanchez B (2023). Electrical Impedance Dermography Differentiates Squamous Cell Carcinoma In Situ from Inflamed Seborrheic Keratoses. JID Innov, 3(3), 100194. (Read full article)
    4. Abbott J, Corean J, Snyder AM, Florell SR, Miles R, Stephens D, Wada DA (2023). Folliculocentric lymphocytic hypersensitivity reactions in CLL/SLL patients: A unique clinicopathologic entity amongst non-specific hypersensitivity reactions. Skin Health Dis, 3(3), e208. (Read full article)
    5. Elkeeb DM, Hopkins ZH, Bolender CM, Moreno C, Florell SR, Bowen AR, Vitale P, Zussman J, Duffy K, Grossman D, Secrest AM, Wada DA (2022). A Single-Institution Cohort Study With Nevi of Special Site: Recurrence, Progression to Melanoma, and Patterns of Management. Am J Dermatopathol, 45(1), 28-39. (Read full article)
    6. Abbott J, Beuning C, Seibert AM, Florell SR, Certain L (2022). Mycetomalike Skin Infection Due to Gordonia bronchialis in an Immunocompetent Patient. Cutis, 110(4), E20-E26. (Read full article)
    7. Clark JJ, Snyder AM, Sreekantaswamy SA, Petersen MJ, Lewis BKH, Secrest AM, Florell SR (2021). Dermatologic care of incarcerated patients: A single-center descriptive study of teledermatology and face-to-face encounters. J Am Acad Dermatol, 85(6), 1660-1662. (Read full article)
    8. Okwundu N, Rahman H, Liu T, Florell SR, Boucher KM, Grossman D (2021). A randomized double-blind placebo-controlled trial of oral aspirin for protection of melanocytic nevi against UV-induced DNA damage. Cancer Prev Res (Phila), 15, 129-138. (Read full article)
    9. Jimenez AR, Florell SR, Donigan JM (2021). Encountering Ethylene Vinyl Alcohol in Dimethyl Sulfoxide Embolization Material During Electrodesiccation and Curettage. Dermatol Surg, 47(10), 1405-1406. (Read full article)
    10. Rahman H, Kumar D, Liu T, Okwundu N, Lum D, Florell SR, Burd CE, Boucher KM, VanBrocklin MW, Grossman D (2020). Aspirin Protects Melanocytes and Keratinocytes against UVB-Induced DNA Damage In Vivo. J Invest Dermatol, 141(1), 132-141.e3. (Read full article)
    11. Varedi A, Rahman H, Kumar D, Catrow JL, Cox JE, Liu T, Florell SR, Boucher KM, Okwundu N, Burnett WJ, VanBrocklin MW, Grossman D (2020). ASA Suppresses PGE2 in Plasma and Melanocytic Nevi of Human Subjects at Increased Risk for Melanoma. Pharmaceuticals (Basel), 13(1). (Read full article)
    12. Flores S, Wada DA, Florell SR, Bowen AR (2019). Pretibial Pruritic Papular Dermatitis: A Comprehensive Clinical and Pathologic Review of Cases at a Single Institution. Am J Dermatopathol, 42(1), 16-19. (Read full article)
    13. Gonzalez CD, Florell SR, Bowen AR, Presson AP, Petersen MJ (2019). Histopathologic vasculitis from the periulcer edge: A retrospective cohort study. J Am Acad Dermatol, 81(6), 1353-1357. (Read full article)
    14. Clark JJ, Hawkes JE, Florell SR, Miles RR, Wada DA (2019). Cutaneous T-Cell Acute Lymphoblastic Leukemia and the Expression Pattern of Terminal Deoxynucleotidyl Transferase Immunostaining in Mycosis Fungoides and Spongiotic Dermatitis. Dermatopathology (Basel), 6(3), 182-188. (Read full article)
    15. Frigerio A, Florell SR, Johnson L (2019). Midline Anterior Neck Inclusion Cyst. J Pediatr, 211, 220. (Read full article)
    16. Bowen AR, Burt L, Boucher K, Tristani-Firouzi P, Florell SR (2012). Use of proliferation rate, p53 staining and perforating elastic fibers in distinguishing keratoacanthoma from hypertrophic lichen planus: a pilot study. J Cutan Pathol, 39(2), 243-50. (Read full article)
    17. Bowen GM, Bowen AR, Florell SR (2011). Lentigo maligna: one size does not fit all. Arch Dermatol, 147(10), 1211-3. (Read full article)
    18. Summers E, Samadashwily G, Florell SR (2011). A unique presentation of an Epstein-Barr virus-associated natural killer/T-cell lymphoproliferative disorder in a white male adolescent. Arch Dermatol, 147(2), 216-20. (Read full article)
    19. Goodson AG, Florell SR, Boucher KM, Grossman D (2010). Low rates of clinical recurrence after biopsy of benign to moderately dysplastic melanocytic nevi. J Am Acad Dermatol, 62(4), 591-6. (Read full article)
    20. Chandler W, Zone J, Florell S (2009). C4d immunohistochemical stain is a sensitive method to confirm immunoreactant deposition in formalin-fixed paraffin-embedded tissue in bullous pemphigoid. J Cutan Pathol, 36(6), 655-9. (Read full article)
    21. Florell SR, Coffin CM (2009). Diagnostically Challenging Melanocytic Lesions in Children. Pathol Case Rev, 14(3), 85-92.
    22. Florell SR, Smoller BR, Boucher KM, Grossman D, Harris RM, Bowen GM, Leachman SA (2008). Sampling of melanocytic nevi for research purposes: a prospective, pilot study to determine effect on diagnosis. J Am Acad Dermatol, 59(5), 814-21. (Read full article)
    23. Florell SR, Meyer LJ, Boucher KM, Grossman D, Cannon-Albright LA, Harris RM, Samlowski WE, Zone JJ, Leachman SA (2008). Increased melanocytic nevi and nevus density in a G-34T CDKN2A/p16 melanoma-prone pedigree. J Invest Dermatol, 128(8), 2122-5. (Read full article)
    24. Florell SR, Thomas J, Grossman D (2007). Predominant formation of heavily pigmented dermal melanocytomas resembling 'animal-type' melanomas in hepatocyte growth factor (C57BL/6 x C3H)F1 mice following neonatal UV irradiation. J Cutan Pathol, 34(9), 667-74. (Read full article)
    25. Wada DA, Perkins SL, Tripp S, Coffin CM, Florell SR (2007). Human herpesvirus 8 and iron staining are useful in differentiating Kaposi sarcoma from interstitial granuloma annulare. Am J Clin Pathol, 127(2), 263-70. (Read full article)
    26. McKenna JK, Florell SR (2007). Cost-effective dynamic telepathology in the Mohs surgery laboratory utilizing iChat AV videoconferencing software. Dermatol Surg, 33(1), 62-8; discussion 68. (Read full article)
    27. Florell SR, Cessna M, Lundell RB, Boucher KM, Bowen GM, Harris RM, Petersen MJ, Zone JJ, Tripp S, Perkins SL (2006). Usefulness (or lack thereof) of immunophenotyping in atypical cutaneous T-cell infiltrates. Am J Clin Pathol, 125(5), 727-36. (Read full article)
    28. Florell SR, Boucher KM, Garibotti G, Astle J, Kerber R, Mineau G, Wiggins C, Noyes RD, Tsodikov A, Cannon-Albright LA, Zone JJ, Samlowski WE, Leachman SA (2005). Population-based analysis of prognostic factors and survival in familial melanoma. J Clin Oncol, 23(28), 7168-77. (Read full article)
    29. Florell SR, Bowen AR, Hanks AN, Murphy KJ, Grossman D (2005). Proliferation, apoptosis, and survivin expression in a spectrum of melanocytic nevi. J Cutan Pathol, 32(1), 45-9. (Read full article)
    30. Florell SR, Meyer LJ, Boucher KM, Porter-Gill PA, Hart M, Erickson J, Cannon-Albright LA, Pershing LK, Harris RM, Samlowski WE, Zone JJ, Leachman SA (2004). Longitudinal assessment of the nevus phenotype in a melanoma kindred. J Invest Dermatol, 123(3), 576-82. (Read full article)
    31. Florell SR, Egan CA, Gregory MC, Zone JJ, Petersen MJ (2001). Eosinophilic fasciitis occurring four weeks after the onset of dialysis in a renal failure patient. J Cutan Med Surg, 5(1), 33-6. (Read full article)

    Case Report

    1. Granger DL, Rosado-Santos H, Lo TS, Florell SR, Shimwella RAT (2020). Functional Impairment of Skin Appendages Due to Peripheral Nerve Involvement by Mycobacterium leprae. Open Forum Infect Dis, 7(10), ofaa419. (Read full article)
    2. Abbott J, Blake J, Secrest AM, Florell SR (2019). Rapidly progressive and fatal case of extragenital cutaneous epithelioid angiosarcoma with visceral involvement. JAAD Case Rep, 6(1), 33-36. (Read full article)
    3. Shah A, Hyngstrom J, Florell SR, Grossman D (2019). Use of the Pigmented Lesion Assay to rapidly screen a patient with numerous clinically atypical pigmented lesions. JAAD Case Rep, 5(12), 1048-1050. (Read full article)

    Letter

    1. Laggis CW, Lamb A, Secrest AM, Ufkes N, Halwani AS, Tao R, Gaffney D, Miles RR, Florell SR, Wada D (2020). Favourable outcomes in folliculotropic mycosis fungoides after multimodality treatment in a single institution. [Letter to the editor]. J Eur Acad Dermatol Venereol, 35(1), e42-e45. (Read full article)
    2. Grossman D, Florell SR, Duffy KL, Bowen GM (2019). Histologic criteria for assessing surgical margins in melanoma in situ. [Letter to the editor]. J Am Acad Dermatol, 82(4), e133-e134. (Read full article)
    3. Florell SR, Meyer LJ, Boucher KM, Hart M, Cannon-Albright LA, Harris RM, Grossman D, Samlowski WE, Zone JJ, Brinton JP, Leachman SA (2005). Nevus distribution in a Utah melanoma kindred with a temperature-sensitive CDKN2A mutation. [Letter to the editor]. J Invest Dermatol, 125(6), 1310-2. (Read full article)